インドの体外受精サービス市場の評価：手順タイプ別、サービスプロバイダー別、エンドユーザー別、地域別、機会および予測、2018～2032年

インドの体外受精サービス市場は、2025～2032年度の予測期間中に13.51％のCAGRを記録し、2024年度の17億4,000万米ドルから2032年度には48億米ドルに成長すると予測されています。

体外受精サービスのインド市場は、最近の体外受精技術の進歩と効率的なソリューションに対する需要の高まりにより、大きく成長しています。同国の市場拡大を後押ししている主な要因のひとつは、座りがちなライフスタイルや環境条件の変化により、国民の多くが生殖機能を低下させていることです。ほとんどの人々は、特にこのような重要で人生を変えるような処置に関して、健康と幸福のために使う余分なお金を持っています。さらに、市場の成長軌道は、ヘルスケア・インフラに対する政府の投資、技術の進歩、最先端のソリューションに対する需要の高まりによって強化されています。特にアジア太平洋地域におけるヘルスケアの急速な進歩は、有利な見通しをもたらしています。例えば、CK Birla Healthcare Pvt.Ltd.は、2024年1月にウッタル・プラデーシュ州ミールートに、様々な不妊問題に対応する新しい不妊治療クリニックを導入しました。

目次

第1章 プロジェクトの範囲と定義

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 インドの体外受精サービス市場の見通し、2018年度～2032年度

• 市場規模の分析と予測
  • 金額別
• 市場シェア分析と予測
  • 手順タイプ別
    • 新鮮ドナーによる体外受精
    • 新鮮な非ドナー体外受精
    • 凍結ドナー体外受精
    • 凍結非ドナー体外受精
    • 自然周期体外受精
    • 胚バンキング（凍結保存）
  • サービスプロバイダー別
    • 不妊治療クリニック
    • 病院
    • 外科センター
    • クライオバンク
  • エンドユーザー別
    • カップル（男性不妊症と女性不妊症）
    • 独身女性
    • LGBTQ+コミュニティ
  • 地域別
    • 北部
    • 南部
    • 東部
    • 西部と中央部
  • 市場シェア分析（上位5社およびその他- 金額別、2024年度）、企業別
• 市場マップ分析、2024年度
  • 手順タイプ別
  • サービスプロバイダー別
  • エンドユーザー別
  • 地域別

すべてのセグメントは、対象となるすべての地域と国で提供されます。

第5章 需要供給分析

第6章 バリューチェーン分析

第7章 ポーターのファイブフォース分析

第8章 PESTLE分析

第9章 価格分析

第10章 市場力学

• 市場促進要因
• 市場の課題

第11章 市場の動向と発展

第12章 特許の情勢

第13章 ケーススタディ

第14章 競合情勢

• 市場リーダー上位5社の競合マトリックス
• 上位5社のSWOT分析
• 市場上位10社の主要企業の情勢
  • Fortis La Femme Hospital
  • 会社概要
  • 主要経営陣
  • 製品とサービス
  • 財務状況（報告通り）
  • 主な市場フォーカスと地理的プレゼンス
  • 最近の動向/コラボレーション/ パートナーシップ/合併と買収
  • Nova Pulse IVF Clinic Private Limited
  • Max Healthcare
  • Miracles Mediclinic, New Delhi
  • Bloom IVF Centre
  • The Indira IVF Hospital Pvt Ltd
  • Science IVF, Delhi
  • The Bourn Hall Clinic
  • Sri Ramakrishna Hospital, Coimbatore
  • Care IVF

上記の企業は市場シェアに基づいて注文を保留しておらず、調査作業中に入手可能な情報に基づいて変更される可能性があります。

第15章 戦略的提言

第16章 調査会社について・免責事項

List of Tables

• Table 1. Competition Matrix of Top 5 Market Leaders
• Table 2. Mergers & Acquisitions/ Joint Ventures (If Applicable)
• Table 3. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

• Figure 1. India In-Vitro Fertilization Services Market, By Value, In USD Billion, FY2018-FY2032F
• Figure 2. India In-Vitro Fertilization Services Market Share (%), By Procedure Type, FY2018-FY2032F
• Figure 3. India In-Vitro Fertilization Services Market Share (%), By Service Provider, FY2018-FY2032F
• Figure 4. India In-Vitro Fertilization Services Market Share (%), By End-user, FY2018-FY2032F
• Figure 5. India In-Vitro Fertilization Services Market Share (%), By Region, FY2018-FY2032F
• Figure 6. By Procedure Type Map-Market Size (USD Billion) & Growth Rate (%), FY2024
• Figure 7. By Service Provider Map-Market Size (USD Billion) & Growth Rate (%), FY2024
• Figure 8. By End-user Map-Market Size (USD Billion) & Growth Rate (%), FY2024
• Figure 9. By Region Map-Market Size (USD Billion) & Growth Rate (%), FY2024

India in-vitro fertilization services market is projected to witness a CAGR of 13.51% during the forecast period FY2025-FY2032, growing from USD 1.74 billion in FY2024 to USD 4.80 billion in FY2032.

Indian market for in-vitro fertilization services has grown significantly owing to the recent advancements in IVF techniques and the growing demand for efficient solutions. One of the primary elements propelling market expansions in the country is most of the population's declining reproductive health due to sedentary lifestyles and shifting environmental conditions. Most people have extra money to spend on their health and well-being, particularly concerning such important and life-changing procedures. Furthermore, the market's growth trajectory is being reinforced by government investments in healthcare infrastructure, technological progression, and the growing demand for cutting-edge solutions. Rapid advancements in healthcare, particularly in Asia-Pacific, present lucrative prospects. For example, CK Birla Healthcare Pvt. Ltd. introduced a new fertility clinic in Meerut, Uttar Pradesh in January 2024 that caters to various fertility issues.

Advancements in Technology Boost India In-Vitro Fertilization Services Market Growth

The in-vitro fertilization (IVF) industry is growing rapidly in India on the backdrop of advancements in technology that have increased treatment effectiveness and success rates. Advances such as time-lapse imaging, preimplantation genetic testing (PGT), and embryo vitrification have improved implantation rates and reduced miscarriage risks, making IVF a more reliable option for infertile couples in recent years. These technological developments have increased patient confidence and expanded the patient pool to include individuals with genetic issues or age-related infertility.

Automation and artificial intelligence (AI), which reduce human error and maximize embryo selection, further revolutionize IVF. The enhanced ability of AI-driven models to accurately evaluate embryo viability increases pregnancy success rates. Additionally, cryopreservation methods, such as freezing oocytes and embryos, allow patients to save their fertility for later use, increasing the demand for IVF services. Due to these advancements, rising awareness, and greater funding in reproductive clinics, IVF procedures are now more accessible and affordable. As success rates increase, IVF is becoming widely popular among individuals and couples, including LGBTQ+ individuals and single parents, which is driving the market's expansion. Thus, IVF technology developments are key to the market's consistent growth. For instance, the government of Goa launched the Intrauterine Insemination /In-Vitro Fertilization and Assisted Reproductive Technology Center in August 2023 at the Goa Medical College and Hospital (GMC). The center provides free infertility treatment.

Rising Awareness and Acceptance Fuel the Market Growth

The expansion of India's fertility business has been greatly aided by the increasing awareness and public acceptance of in-vitro fertilization (IVF). Infertility was once a taboo topic, but because of healthcare initiatives, media influence, and education, there is now more openness and acceptance of IVF procedures. Due to better access to information through digital platforms and healthcare campaigns, couples who are having trouble conceiving are now more likely to look for medical options.

Furthermore, IVF is now more widely available due to the growth of fertility clinics in Tier 2 and Tier 3 cities, affordable treatment choices, and government initiatives. The industry has grown owing to shifting attitudes, the acceptance of IVF among LGBTQ+ people and single parents, and corporate insurance coverage for fertility treatments. For instance, Nova IVF introduced "Fertility Tales," a podcast project in November 2023, to raise awareness about fertility treatment through engaging narratives. The podcast interviews industry stakeholders and shares real patient stories about firsthand experiences with IVF treatment.

Rising Infrastructure Drive India In-Vitro Fertilization Services Market Growth

The in-vitro fertilization (IVF) market has grown tremendously due to India's rapidly developing healthcare infrastructure. Fertility treatments are now more widely available due to the construction of specialized fertility centers, cutting-edge reproductive laboratories, and enhanced hospital facilities throughout metropolitan and semi-urban areas. Prominent healthcare organizations such as Apollo, Fortis, and Nova IVF Fertility have extended their IVF offerings by incorporating state-of-the-art technology such as genetic testing, sophisticated cryopreservation, and AI-based embryo selection.

Infrastructure development is tremendously accelerated by government efforts such as Public-Private Partnerships (PPP) and greater foreign investments. Furthermore, the growth of medical tourism has drawn people from all over the world due to India's high-quality fertility therapies and affordability. IVF adoption is also fueled by improved healthcare accessibility and connection in tier-2 and tier-3 cities. With continuous investments in healthcare infrastructure and innovation, India's IVF market is set for exponential growth, catering to rising infertility rates and evolving patient needs.

For example, in February 2024, Sabine Hospital, an IVF hospital based in Kerala, announced the installation of a Next Generation Sequencer (NGS), to detect genetic diseases in the developing fetus while the fetus is still in the womb.

Future Market Scenario (FY2025 - FY2032F)

Many factors claim the growth of India in-vitro fertilization service market. Technological advancements give faster and more accurate results leading us to early diagnosis. Opportunity also lies in the increasing fertility concerns the population faces today. Promising initiatives of our government that provide healthcare infrastructure, funds to carry on research and development on a large scale, and a reliable distribution channel that ensures the solution reaches everyone is testimonial.

For instance, in December 2023, Little Angel IVF launched in-vitro fertilization treatments such as personalized fertility consultation, comprehensive diagnostic services, advanced IVF treatments, and intracytoplasmic sperm injection (ICSI) for Non-Resident Indian patients.

Key Players Landscape and Outlook

Key players in the in-vitro fertilization services industry utilize mergers, acquisitions, partnerships, and new product launches to improve their services and competitiveness. Such efforts will propel significant growth in the market, allowing big-cap industry players to increase their presence and, therefore, find new opportunities in this market.

For instance, in June 2023, Nova Pulse IVF Clinic Private Limited acquired WINGS IVF, a regional IVF chain based in Ahmedabad. This acquisition expands Nova IVF Fertility's reach to 68 centers in 44 cities.

In March 2023, Santaan Fertility Center & Research Institute Private Limited launched a new fertility clinic and research institute in Odisha, India, and Indira IVF opened its 116th IVF center in Pune, Maharashtra, an addition to the existing center in Pune.

Table of Contents

1. Project Scope and Definitions

2. Research Methodology

3. Executive Summary

4. India In-Vitro Fertilization Services Market Outlook, FY2018-FY2032F

• 4.1. Market Size Analysis & Forecast
  • 4.1.1. By Value
• 4.2. Market Share Analysis & Forecast
  • 4.2.1. By Procedure Type
    • 4.2.1.1. Fresh Donor IVF
    • 4.2.1.2. Fresh Non-Donor IVF
    • 4.2.1.3. Frozen Donor IVF
    • 4.2.1.4. Frozen Non-Donor IVF
    • 4.2.1.5. Natural Cycle IVF
    • 4.2.1.6. Embryo Banking (Cryopreservation)
  • 4.2.2. By Service Provider
    • 4.2.2.1. Fertility Clinics
    • 4.2.2.2. Hospitals
    • 4.2.2.3. Surgical Centers
    • 4.2.2.4. Cryobanks
  • 4.2.3. By End-user
    • 4.2.3.1. Couples (Male and Female Infertility)
    • 4.2.3.2. Single Women
    • 4.2.3.3. LGBTQ+ Community
  • 4.2.4. By Region
    • 4.2.4.1. North
    • 4.2.4.2. South
    • 4.2.4.3. East
    • 4.2.4.4. West and Central
  • 4.2.5. By Company Market Share Analysis (Top 5 Companies and Others - By Value, FY2024)
• 4.3. Market Map Analysis, FY2024
  • 4.3.1. By Procedure Type
  • 4.3.2. By Service Provider
  • 4.3.3. By End-user
  • 4.3.4. By Region

All segments will be provided for all regions and countries covered

5. Demand Supply Analysis

6. Value Chain Analysis

7. Porter's Five Forces Analysis

8. PESTLE Analysis

9. Pricing Analysis

10. Market Dynamics

• 10.1. Market Drivers
• 10.2. Market Challenges

11. Market Trends and Developments

12. Patent Landscape

13. Case Studies

14. Competitive Landscape

• 14.1. Competition Matrix of Top 5 Market Leaders
• 14.2. SWOT Analysis for Top 5 Players
• 14.3. Key Players Landscape for Top 10 Market Players
  • 14.3.1. Fortis La Femme Hospital
    • 14.3.1.1. Company Details
    • 14.3.1.2. Key Management Personnel
    • 14.3.1.3. Products and Services
    • 14.3.1.4. Financials (As Reported)
    • 14.3.1.5. Key Market Focus and Geographical Presence
    • 14.3.1.6. Recent Developments/Collaborations/Partnerships/Mergers and Acquisition
  • 14.3.2. Nova Pulse IVF Clinic Private Limited
  • 14.3.3. Max Healthcare
  • 14.3.4. Miracles Mediclinic, New Delhi
  • 14.3.5. Bloom IVF Centre
  • 14.3.6. The Indira IVF Hospital Pvt Ltd
  • 14.3.7. Science IVF, Delhi
  • 14.3.8. The Bourn Hall Clinic
  • 14.3.9. Sri Ramakrishna Hospital, Coimbatore
  • 14.3.10. Care IVF

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

15. Strategic Recommendations

16. About Us and Disclaimer